Breaking News Instant updates and real-time market news.

PCTY

Paylocity

$63.90

0.03 (0.05%)

16:14
08/09/18
08/09
16:14
08/09/18
16:14

Paylocity sees Q1 revenue of $97.5M-$98.5M, consensus $99.5M

Sees Q1 adjusted EBITDA, a non-GAAP measure, in the range of $20M-$21M.

  • 09

    Aug

  • 13

    Aug

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

  • 05

    Sep

  • 12

    Sep

PCTY Paylocity
$63.90

0.03 (0.05%)

03/15/18
NEED
03/15/18
NO CHANGE
Target $65
NEED
Buy
Paylocity price target raised to $65 from $60 at Needham
Needham analyst Scott Berg raised his price target on Paylocity to $65 after meeting with the company CEO Steve Beauchamp, saying he is more positive about the health of end-market demand and subscription revenue growth objective of 20%. Berg keeps his Buy rating, adding that the CEO commentary highlighted some recent smaller customer deals within the multi-year SaaS upgrade cycle in HR/payroll that has several years left to run.
03/23/18
STFL
03/23/18
DOWNGRADE
Target $100
STFL
Hold
Paycom downgraded to Hold from Buy at Stifel
Stifel analyst Brad Reback downgraded shares of Paycom (PAYC) to Hold from Buy, telling investors in a research note that he does not expect shares to outperform over the next twelve months, despite viewing Paycom as a leading mid-market human capital management, or HCM, provider and believes shares "deserve" to trade at some premium to Ultimate Software (ULTI) and Paylocity (PCTY) given modestly-higher growth and significantly-higher operating margin. Overall, Reback believes Paycom has "limited" penetration of a large market opportunity that, coupled with other drivers like further penetrating existing territories, new sales offices and improving sales productivity, should enable healthy double-digit top- line growth and strong profitability in coming years. Reback raised his price target to $100 from $90.
04/23/18
RBCM
04/23/18
DOWNGRADE
RBCM
Sector Perform
Paylocity downgraded to Sector Perform from Outperform at RBC Capital
04/23/18
RBCM
04/23/18
DOWNGRADE
Target $56
RBCM
Sector Perform
Paylocity downgraded to Sector Perform at RBC Capital on tighter competition
As reported earlier, RBC Capital analyst Ross MacMillan downgraded Paylocity to Sector Perform from Outperform, citing his expectations of a more competitive mid-market payroll space over the next 12-18 months. The analyst also notes that the company' operating margin expansion may be constrained amid changes in the company's sales productivity. MacMillan raises his price target Paylocity however to $56 from $51.

TODAY'S FREE FLY STORIES

MDT

Medtronic

$92.39

-0.41 (-0.44%)

11:46
02/21/19
02/21
11:46
02/21/19
11:46
Conference/Events
Medtronic participates in a conference call with JPMorgan »

Healthcare Analyst Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 06

    Mar

  • 18

    May

  • 28

    May

S

Sprint

$6.43

0.115 (1.82%)

11:45
02/21/19
02/21
11:45
02/21/19
11:45
Options
Sprint call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 11

    Mar

  • 11

    Mar

BIIB

Biogen

$322.54

-12.47 (-3.72%)

, RHHBY

Roche

$0.00

(0.00%)

11:44
02/21/19
02/21
11:44
02/21/19
11:44
On The Fly
Biogen downgrade, cannabis sector initiation among today's top analyst calls »

Check out today's top…

BIIB

Biogen

$322.54

-12.47 (-3.72%)

RHHBY

Roche

$0.00

(0.00%)

X

U.S. Steel

$24.06

0.06 (0.25%)

AAN

Aaron's

$53.84

0.2 (0.37%)

BBY

Best Buy

$60.11

-0.15 (-0.25%)

DHI

D.R. Horton

$39.76

-0.11 (-0.28%)

LEN

Lennar

$48.81

-0.15 (-0.31%)

APHA

Aphria

$10.33

0.17 (1.67%)

KSHB

KushCo Holdings

$0.00

(0.00%)

HEXO

HEXO Corp

$5.89

-0.09 (-1.51%)

CGC

Canopy Growth

$45.25

-0.93 (-2.01%)

ACB

Aurora Cannabis

$7.07

0.01 (0.14%)

TLRY

Tilray

$79.49

-1.58 (-1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 04

    Mar

  • 05

    Mar

  • 05

    Mar

  • 06

    Mar

  • 11

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 04

    Apr

  • 28

    May

  • 19

    Aug

MNSB

MainStreet Bancshares

$0.00

(0.00%)

11:42
02/21/19
02/21
11:42
02/21/19
11:42
Hot Stocks
MainStreet Bancshares applies to list common stock on NASDAQ Capital Market »

MainStreet Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZSAN

Zosano Pharma

$4.19

1.98 (89.59%)

11:40
02/21/19
02/21
11:40
02/21/19
11:40
Recommendations
BTIG boosts Zosano target to $19 on 'solid' migraine safety data »

BTIG analyst Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:38
02/21/19
02/21
11:38
02/21/19
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
02/21/19
02/21
11:38
02/21/19
11:38
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

UNIT

Uniti Group

$11.23

-1.035 (-8.44%)

11:35
02/21/19
02/21
11:35
02/21/19
11:35
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 11

    Mar

  • 11

    Mar

ZSAN

Zosano Pharma

$3.89

1.68 (76.02%)

11:32
02/21/19
02/21
11:32
02/21/19
11:32
Hot Stocks
Breaking Hot Stocks news story on Zosano Pharma »

Zosano Pharma jumps 100%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Conference/Events
UBS leisure/lodging analyst to hold an analyst/industry conference call »

Leisure, Gaming &…

ZSAN

Zosano Pharma

$3.89

1.68 (76.02%)

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Hot Stocks
Zosano says Qtrypta long-term study shows 'well-tolerated safety profile' »

Zosano Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$4.85

-0.05 (-1.02%)

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Hot Stocks
Zynerba patent listed by World Intellectual Property Organization »

The patent listed by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$24.23

-0.45 (-1.82%)

11:25
02/21/19
02/21
11:25
02/21/19
11:25
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 04

    Mar

  • 20

    Mar

KMTUY

Komatsu

$0.00

(0.00%)

11:21
02/21/19
02/21
11:21
02/21/19
11:21
Downgrade
Komatsu rating change  »

Komatsu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
02/21/19
02/21
11:20
02/21/19
11:20
General news
Treasury announced $113 B in shorter dated coupon sales for next week »

Treasury announced $113 B…

SCI

Service Corp.

$42.31

-0.42 (-0.98%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Hot Stocks
Service Corp. raises quarterly cash dividend 6% to 18c per share »

Service Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
02/21/19
02/21
11:16
02/21/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

GS

Goldman Sachs

$197.12

-1.49 (-0.75%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Initiation
Goldman Sachs initiated  »

Odeon's Dick Bove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

  • 12

    Mar

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DK

Delek US

$36.95

-0.13 (-0.35%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Options
Delek US draws upside call buyers as shares slip off early highs »

Delek US draws upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Existing home sales fell 1.2% in January to 4.99 M, a 3-year low »

Existing home sales fell…

11:08
02/21/19
02/21
11:08
02/21/19
11:08
General news
3-Month Bill Announcement CUSIP Number data reported »

3-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.